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Scl and Lyl1 encode two related basic-helix-loop-
helix transcription factors implicated in T cell acute
lymphoblastic leukemia. Previous studies showed
that Scl is essential for embryonic and adult erythro-
poiesis,whileLyl1 is important forBcell development.
Single-knockout mice have not revealed an essential
function for Scl or Lyl1 in adult hematopoietic stem
cells (HSCs). To determine if maintenance of HSCs
in single-knockout mice is due to functional redun-
dancy, we generated Lyl1;Scl-conditional double-
knockout mice. Here, we report a striking genetic
interaction between the two genes, with a clear
dose dependence for the presence of Scl or Lyl1
alleles for HSC function. Bone marrow repopulation
assays and analyses demonstrated rapid loss of
hematopoietic progenitors due to apoptosis. The
function of HSCs could be rescued by a single allele
ofLyl1butnotScl. These results showthatexpression
of at least one of these factors is essential for mainte-
nance of adult HSC function.
INTRODUCTION
Bone marrow hematopoietic stem cells (HSCs) can self-renew
and differentiate to generate the diverse lineages of the blood.
Critical in hematopoietic development and adult homeostasis
are a number of transcription factors, many of which are dysre-
gulated in human leukemias (Look, 1997; Murre, 2000; Rabbitts,
1994; Shivdasani and Orkin, 1996; Tenen, 2003).
The Stem Cell Leukemia gene (SCL/TAL1), first identified
at a translocation breakpoint in T cell acute lymphoblastic
leukemia (T-ALL), is a tissue-restricted member of the basic-
helix-loop-helix (bHLH) class of transcription factors that has
been termed a master regulator of hematopoiesis because
gene-targeting studies have shown that it is essential for the
formation of HSCs (Robb et al., 1995; Shivdasani et al., 1995).
However, conditional deletion of Scl in adult HSCs has rela-
tively little effect: Scl null adult HSCs have impaired short-
term repopulating ability, predominantly of the myeloid lineage,
but no defects in long-term repopulation or self-renewal (Curtis
et al., 2004). Thus, Scl is essential for the formation but not
maintenance of adult HSCs (Mikkola et al., 2003).
A possible explanation for redundancy of Scl in adult HSCs is
expression of the related bHLH transcription factor Lyl1.
However, Lyl1 cannot rescue early lethality of Scl null mice
despite similar patterns of embryonic expression (Giroux et al.,
2007), and enforced expression of Lyl1 in Scl/ embryonic
stem cells did not rescue their defective development (Porcher
et al., 1999), arguing that Lyl1 cannot compensate for Scl in
developmental hematopoiesis.
In adult hematopoiesis, Lyl1 is expressed more broadly than
Scl, in myeloid and B cell lineages as well as HSCs. In contrast
to Scl, Lyl1 is dispensable for hematopoietic development.
Transplantation assays of Lyl1 null HSCs revealed defective
lymphoid but normal myeloid repopulation, suggesting that
Lyl1 is also dispensable for adult HSCs (Capron et al., 2006).
To examine the possibility that Scl and Lyl1 can compensate
for each other in adult HSCs, we generated Lyl1;Scl-conditional
double-knockout mice to study the potential genetic interaction
between the two genes in adult hematopoiesis.
RESULTS
Strong Selective Pressure against Loss of Scl in Lyl1
Null Myeloid Progenitors
To examine possible functional redundancy between Lyl1 and
Scl, we generated Mx-Cre;Lyl1/;Sclfl/fl mice. Blood counts
including platelets in mice lacking one or both alleles of Lyl1
were normal prior to deletion of the Sclfl alleles (see Figure S1A
available online). Four weeks after deletion of the Sclfl allele
(SclD), Mx;Lyl1/;SclD/D mice had a higher platelet count
compared with Mx;Lyl1+/;SclD/D mice (Figure S1B). Other blood
parameters including red cells and B cells were normal in
Mx;Lyl1/;SclD/D and control mice (data not shown). Unlike
the original report (Capron et al., 2006), our Lyl1 null colony
had normal numbers of peripheral blood B cells.
Eightweeks afterpoly(I:C), we observed reducedMeg-CFC and
BFU-E and increased mast-CFC in control Mx;Lyl1+/+;SclD/D and
Mx;Lyl1+/;SclD/D mice as we previously described (Hall et al.,
2003; Salmon et al., 2007). Remarkably, Mx;Lyl1/; SclD/D mice
had normal numbers of BFU-E (Figure S1C) Meg-CFC and no
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Lyl1 Compensates for Scl in HSCFigure 1. Mx;Lyl1/;SclD/D HSCs Cannot
Contribute to Steady-State Hematopoiesis
(A) Myeloid colony numbers and types generated
from agar cultures of 25,000 bone marrow cells
4 weeks after poly(I:C) (mean, n = 3 mice).
(B) PCR genotyping of theSclfl allele in single gran-
ulocyte/macrophage (GM) or BFU-E colonies
grown from bone marrow of Mx;Lyl1+/;SclD/D
and Mx;Lyl1/;SclD/D mice.
(C) Schematic of experimental design. Whole bone
marrow from CD45.2 WT, Lyl1/, Mx;Sclfl/fl, and
Mx;Lyl1/;SclD/D mice was isolated and trans-
planted into lethally irradiated recipients (n = 8).
Engraftment was assessed prior to poly(I:C)
4 weeks after transplant. Recipient mice then
received three doses of poly(I:C) on alternate
days and were analyzed initially 2 weeks after the
first treatment.
(D) Contribution of donor cells with the indicated
genotypes to peripheral blood, as analyzed by
flow cytometry using the CD45.2 marker (mean ±
SEM).
(E and F) PCR genotyping for the Sclfl allele of
donor-derived cells in recipient mice (colonies
from poly(I:C) treatment before transplant [E] and
after the transplant [F]). CD45.2+ cells were sorted
and cultured in methylcellulose medium, and colo-
nies were genotyped for excision of the floxed Scl
allele. Representative colony PCR shows that all of
the engrafted donor-derived cells are nondeleted
for the Scl allele.
(G) Competitive transplant assay as in (C) to
assess the function of Mx;Lyl1+/;SclD/D HSCs.
A three-fold excess of donor cells was used, and
peripheral blood contribution was assessed at
four-week intervals. All experiments were
repeated at least twice with similar results each
time (mean ± SEM).aberrant mast cell differentiation (Figure 1A). There were two
possible explanations for improved platelet count and progenitor
growth in Mx;Lyl1/;SclD/D mice: either selective outgrowth of
nondeleted, Scl-expressing (Sclfl/fl) progenitors, or the absence
of Lyl1 rescued SclD/D growth defects. Southern blot of hemato-
poietic organs from Mx;Lyl1/;SclD/D mice showing almost no
deleted Sclfl allele suggested that selection of nondeleted Sclfl/fl
cells was the most likely explanation (Figure S1D). To definitively
demonstrate that myeloid and erythroid colonies generated from
Mx;Lyl1/;SclD/D mice were derived from Sclfl/fl progenitors,
single colonies were genotyped, revealing that all myeloid and
BFU-E progenitors from Mx;Lyl1/;SclD/D mice had at least one
Sclfl allele (Figure 1B). In contrast, all colonies from control
Mx;Lyl1+/;SclD/D mice were Scl deleted (SclD/D). These results
indicate that SclD/D myeloid progenitors have a significant growth
disadvantage in the absence of Lyl1.
Lyl1;Scl Double-Knockout Hematopoietic Stem Cells
Cannot Repopulate Lethally Irradiated Recipients
or Contribute to Steady-State Hematopoiesis
To determine whether the defect observed in myeloid progen-
itors extended to HSCs, we performed competitive repopula-
tion assays using whole bone marrow obtained from
Mx;Lyl1/;SclD/D mice. Mice were injected three times with
poly(I:C) on alternate days, and bone marrow cells were
harvested for transplantation the day following the last injection
to minimize potential outgrowth of nondeleted Sclfl/fl HSCs
(Figure S2A). Peripheral blood analysis revealed that
Mx;Lyl1/;SclD/D bone marrow cells contributed to less than
1% of the recipients’ peripheral blood production compared
with wild-type (WT) bone marrow donor cells, which comprised
approximately 40% of hematopoiesis by 16 weeks (Figure S2B).
Both Lyl/ and Mx;SclD/D single-knockout bone marrow cells
exhibited milder repopulating defects as previously reported
(Capron et al., 2006; Curtis et al., 2004). Even with a 25-fold
excess of transplanted donor cells, Mx;Lyl1/;SclD/D gave rise
to only 4% engraftment 16 weeks posttransplant (Figure S2C).
The inability of Mx;Lyl1/;SclD/D HSCs to repopulate and
expand in lethally irradiated recipients could be due to a homing
defect. Therefore, we repeated the transplantation assay
inducing deletion of the Scl alleles after, rather than before,
transplantation (Figure 1C). Five to six weeks after transplant,
recipient mice received three doses of poly(I:C) every other day
to induce deletion of the Sclfl allele, and initial peripheral blood
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Lyl1 Compensates for Scl in HSCchimerism was determined 2 weeks later. Hematopoietic contri-
bution by Mx;Lyl1/;Sclfl/fl HSCs fell from 20% to less than
5% within 2 weeks after the start of poly(I:C) administration
(Figure 1D), whereas there was no significant effect of poly(I:C)
administration on contribution by WT or single-knockout donor
cells.
To determine the status of the Scl allele of the cells derived
from Mx;Lyl1/;Sclfl/fl HSCs after poly(I:C), we sorted donor
CD45.2+ bone marrow cells into methylcellulose medium to
generate colonies for PCR genotyping. All donor-derived cells
in both transplant experiments contained at least one Sclfl allele
(Figures 1E and 1F). These nondeleted cells had escaped
deletion but did not increase over time because the WT compet-
itor cells had eliminated selective pressure for expansion. HSCs,
therefore, require either Lyl1 or Scl to contribute to steady-state
adult hematopoiesis. To examine if one allele of Lyl1 was suffi-
cient to maintain HSC function in the absence of Scl, we tested
donor bone marrow cells with the genotype Mx;Lyl1+/;Sclfl/fl.
Compared with Mx;Lyl1/;SclD/D cells, Mx;Lyl1+/;SclD/D cells
provided stable hematopoiesis for at least 16 weeks after
deletion of theSclfl allele (Figure 1G). PCR genotyping of colonies
derived from sorted donor Mx;Lyl1+/;SclD/D cells confirmed the
Scl null (SclD/D) genotype (data not shown). These results
demonstrate that a single allele of Lyl1 in the absence of Scl is
sufficient to maintain HSC activity.
Dosage Effect of Lyl1 and Scl on HSC Activity
The data above suggested that one WT Lyl1 allele was sufficient
to maintain adult HSC function. To examine if one WT Scl allele
was sufficient, we crossed the Lyl1/ mice to Scl+/ mice
(Elefanty et al., 1998). By using Scl+/ mice rather than
Mx;Scl+/fl mice, we avoid the complications of competition
between HSCs bearing nondeleted Sclfl and deleted SclD
alleles. Since Lyl1/;Scl+/ pups are not viable, as previously
reported (Chan et al., 2007), we examined HSC activity using
14.5 dpc fetal liver, where HSCs reside during late develop-
ment. Lyl1+/, Lyl1/, Lyl1+/;Scl+/ and Lyl1/;Scl+/ fetal
liver cells were assayed by competitive transplantation against
WT bone marrow (Figure 2A). Lyl1/ fetal liver cells had
a mild repopulation defect compared with Lyl1+/ or Lyl1+/;
Scl+/ fetal liver cells (Figure 2B). Remarkably, Lyl1/;Scl+/
fetal liver HSCs had a severe repopulation defect with almost
complete absence of donor cells by 8 weeks posttransplant.
Thus, a single Scl allele in the absence of Lyl1 was unable to
maintain HSC activity.
Scl or Lyl1 Is Required for Survival of Adult Progenitors
and HSCs
The inability to identify Mx;Lyl1/;SclD/D cells in Mx;Lyl1/;
Sclfl/fl mice after poly(I:C) or competitive transplantation (Figure 1)
suggested that expression of either Scl or Lyl1 is essential for the
survival, growth, or differentiation of adult HSCs. In order to
determine the fate of Mx;Lyl1/;SclD/D HSCs, we treated
Mx;Lyl1/;Sclfl/fl mice with poly(I:C) for six injections on alter-
nate days and harvested bone marrow cells 2 hr after the last
injection. Mx;Lyl1+/;Sclfl/fl mice were used as controls because
they had normal repopulating activity (Figure 1G). Flow cytomet-
ric analysis of Mx;Lyl1/;SclD/D bone marrow revealed a normal
number of lineage-negative cells (Linneg) but a variable, and on
occasions dramatic, loss of Linneg c-Kit+ Sca-1 cells (LK) and
the more immature Linneg c-Kit+ Sca-1+ cells (LKS) (Figure 3A).
Overall, there was a two-fold loss of LK cells and LKS cells imme-
diately after Scl deletion (Figure 3B). Annexin V expression on LK
cells revealed a three-fold increase in apoptotic cells (Figure 3C).
PCR genotyping confirmed that most LKS cells were truly
Mx;Lyl1/;SclD/D but the LK fraction contained significant
numbers of nondeleted Sclfl cells (Figure 3D). Culture of
Mx;Lyl1/;SclD/D LKS generated ten-fold fewer colonies than
control cultures (Figure 3E), and PCR genotyping demonstrated
that all colonies from Mx;Lyl1/;SclD/D LKS cells were derived
from either Scl-heterozygous (SclD/fl) or Scl-wild-type (Sclfl/fl)
cells (Figure 3F). Colonies from sorted Mx;Lyl1/;SclD/D LK cells
were mostly Scl-wild-type (Figure 3G), consistent with selection
of nondeleted cells in the transition from LKS to LK cells
(Figure 3D). Consistent with normal HSC activity of Mx;Lyl1+/;
SclD/D cells (Figure 1G), all colonies from Mx;Lyl1+/;Sclfl/fl LK
cells were fully deleted (Figure 3G).
Apoptosis of the Lyl1/Scl Donor Cells Is Cell Intrinsic
The analyses of Mx;Lyl1/;SclD/D mice immediately after
poly(I:C) suggested that apoptosis was the explanation for the
rapid loss of donor Mx;Lyl1/;SclD/D cells in the transplanted
mice (Figure 1B). To test this, recipients of bone marrow from
Mx;Lyl1/; Sclfl/fl mice were given one dose of poly(I:C) and
were analyzed 2 days later. The contribution of Mx;Lyl1/;
SclD/D cells to bone marrow was three times lower in the
poly(I:C)-treated mice than the PBS-treated controls as early as
2 days after treatment (Figure 4A). The percentage of apoptotic
and dead cells, measured with Annexin V staining, was almost
50% of the total donor-derived cells, and three-fold greater than
the controls. Analysis of the WT competitor cells in the same mice
Figure 2. Dose Dependence of Lyl1 and Scl
Alleles on Hematopoietic StemCell Engraft-
ment Potential
(A) Schematic of the transplantation scheme. Fetal
liver (FL) cells from Lyl1+/, Lyl1/, Lyl1+/;Scl+/,
and Lyl1/ ;Scl+/ embryos (CD45.2) at 14.5 dpc
were isolated, mixed at a 2:1 ratio with WT
competitor bone marrow (CD45.1) (500,000 FL
versus 250,000 BM cells), and transplanted into
lethally irradiated recipients.
(B) Peripheral blood (PB) analysis showing the
proportion of nucleated cells derived from the
test population at 4 and 12 weeks after transplan-
tation (mean ± SEM, n = 7). Two replicates of the
experiment showed the same results.
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Lyl1 Compensates for Scl in HSCFigure 3. Analysis of Hematopoiesis in Mx;Lyl1/;SclD/D Mice Immediately after Poly(I:C) Treatment
(A) Flow cytometric analysis of bone marrow cells from Mx;Lyl1+/;Sclfl/fl and Mx;Lyl1/;Sclfl/fl mice 2 hr after the final poly(I:C) injection. Viable cells were stained
for expression of lineage markers (Mac-1, B220, CD3, TER119), c-kit, and Sca-1. The gates used for lineage-negative (Linneg), Linneg c-Kit+ Sca-1 (LK), and Linneg
c-Kit+ Sca-1+ (LKS) cells are shown.
(B) Percentage of LK and LKS cells of bone marrow cells from Mx;Lyl1+/;Sclfl/fl and Mx;Lyl1/;Sclfl/fl mice. Mean and SD of at least seven mice. *p < 0.05
Student’s t test.
(C) Percentage of viable LK and LKS cells expressing Annexin V (mean ± SD, n > 4). *p < 0.05.
(D) Dose titration curve for PCR genotyping (top gel). PCR genotyping of sorted cells (bottom gel).
(E) Myeloid colony numbers generated from agar cultures of 250 LKS cells (mean ± SD, n = 3 mice).
(F) PCR genotyping for deletion of the Sclfl alleles in single granulocyte/macrophage colonies generated from culture of Mx;Lyl1/;SclD/D LKS cells.
(G) PCR genotyping for deletion of the Sclfl alleles in colonies generated from culture of Mx;Lyl1/;SclD/D and Mx;Lyl1+/;SclD/D LK cells. Experiments were
repeated multiple times with consistent results.showed no difference (Figure 4B), suggesting that this phenotype
is cell intrinsic and unique to the Mx;Lyl1/;SclD/D cells.
In order to exclude the possibility of toxicity by poly(I:C) or an
effect of the microenvironment, we induced deletion of the Sclfl
allele in vitro. Bone marrow progenitors (Sca-1+) were isolated
from Lyl1/;Sclfl/fl mice and transduced with an MSCV-based
retroviral vector that carries the Cre recombinase gene coupled
to GFP, or a control GFP-only vector. Cells were cultured for
48 hr, and the GFP-positive fraction was analyzed for apoptosis
using Annexin V (Figure 4C). Strikingly, 23% of the Lyl1/;
SclD/D Sca1+ progenitor cells that were transduced with the
Cre-expressing virus were apoptotic, four times higher than the
control group (Figure 4D). This suggests that the increased rate
of apoptosis of the Mx;Lyl1/;SclD/D cells is cell intrinsic and
independent of the environment and takes place rapidly after
deletion of the Scl allele. These results demonstrate that HSCs
and progenitors lacking both Lyl1 and Scl cannot survive.
DISCUSSION
Scl has been extensively studied and found to be a crucial factor
in hematopoietic development; loss of Scl during embryonic
development leads to absence of hematopoietic progenitors
and vascular defects (Robb et al., 1995; Shivdasani et al.,
1995). Surprisingly, conditional loss of Scl in the adult impacts
short-term, but not long-term repopulation (Curtis et al., 2004),
leading to the assertion that Scl is dispensable for maintenance
of HSCs after development (Mikkola et al., 2003). Lyl1 is a related
bHLH transcription factor with near identity in the bHLH region,
and a similar expression pattern (Giroux et al., 2007). We thus
hypothesized that some redundancy exists between the two
genes, despite the inability of Lyl1 to rescue Scl during develop-
ment (Chan et al., 2007; Porcher et al., 1999). By inducing Scl
deletion on a Lyl1/ background, we investigated a potential
collaboration between these two genes for maintenance of adult
hematopoiesis. Our results demonstrate that Lyl1 is essential
for maintaining normal HSC function in the absence of Scl.
Specifically, Scl null HSCs expressing a single allele of Lyl1
(Lyl1+/;SclD/D) engraft normally in transplantation assays and
can maintain long-term hematopoiesis while Lyl1/;SclD/D
HSCs undergo rapid apoptosis. Therefore, adult Scl null HSCs
survive because of functional redundancy with Lyl1, indicating
that bHLH factors are critical not only for the formation of HSCs
but also for their maintenance in the adult.
Functional redundancy is a feature of other bHLH proteins in
other cell types. For example, during development of skeletal
muscle, MyoD and Myf5 exhibit functional redundancy early in
the myogenic lineage in establishing myoblast identity (Rawls
et al., 1998). In a similar way, a threshold may be required in adult
HSCs in order to maintain optimal function. Increasing loss of
additional alleles of Lyl1 and Scl leads to proportional loss of
HSC function, as illustrated most clearly in Figure 2.
Analyses immediately following poly(I:C) demonstrated
a relatively pure population of Mx;Lyl1/;SclD/D cells within the
LKS cell fraction; however, these cells were unable to grow in
culture (Figure 3). This failure to grow was reflected by the
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Lyl1 Compensates for Scl in HSCFigure 4. Apoptosis of theMx;Lyl1/;SclD/D
Cells Is Cell Intrinsic
(A) Bone marrow engraftment of Mx;Lyl1/;Sclfl/fl
cells treated with either PBS or poly(I:C). Periph-
eral blood (PB) chimerism was analyzed 2 days
after treatment. Mice treated with poly(I:C) had
a three-fold lower engraftment than mice treated
with PBS (mean ± SEM, n = 4).
(B) Annexin V staining on the remaining donor-
derived population in recipients shows that
Mx;Lyl1/;SclD/D donor-derived cells undergo
apoptosis at three times higher rates than
controls. The experiment was carried out four
times with consistent results.
(C) Experimental schematic. Sca1+ cells were
cultured for 48 hr after transduction with a Cre-ex-
pressing virus and analyzed by Annexin V staining.
(D) Representative flow cytometry plots of in vitro
deletion of the Sclfl alleles. The plots shown have
been gated from the GFP-positive populations
and show specific apoptosis of Lyl1/;Sclfl/fl cells
transduced with the Cre-expressing retrovirus.
Transduction experiments were carried out twice
with similar results.presence of cells with the nondeleted Sclfl allele within the more
mature LK progenitor cell fraction (Figure 3D). The increased
expression of Annexin V on LKS and LK cells suggests that
survival of primitive progenitors, including HSCs, is dependent
on the presence of at least one of these bHLH factors. Because
hematopoiesis is a dynamic process with many stem cells and
progenitors generating progeny at any given time, a growth
advantage of cells with one wild-type Scl allele would rapidly
result in their predominance. Therefore, we cannot exclude the
possibility that some Lyl1/;SclD/D cells remain alive but quies-
cent and that Lyl1 or Scl are required for expansion of primitive
progenitors in vivo.
The functional redundancy between Lyl1 and Scl in adult
HSCs is surprising given the inability of Lyl1 to rescue Scl null
hematopoiesis (Chan et al., 2007; Porcher et al., 1999). However,
the two genes have almost identical bHLH domains, and there-
fore similar DNA and protein binding properties to E proteins
(Miyamoto et al., 1996) and Lmo2 (Wadman et al., 1994), genes
essential for hematopoietic development and lineage commit-
ment. The rapid death of Lyl1/;SclD/D cells makes it chal-
lenging to determine the precise downstream mediators of this
effect. However, given the broad range of interactions of bHLH
proteins and the wide range of transcriptional target genes, the
phenotype that we observe in the double knockouts most likely
arises due to disruption of multiple transcription networks. Tran-
scriptional targets that could contribute to the phenotype include
c-kit,Gata2, and Runx1, which are targets of Scl, possibly also of
Lyl1, and have been implicated in the regulation of HSC survival
and proliferation (Krosl et al., 1998; Landry et al., 2008; Pimanda
et al., 2007).
The clear dose sensitivity for optimal HSC engraftment that is
evident with decreasing allele number (Figure 2) highlights the
relatively narrow tolerance for perturbations in the amounts of
bHLH transcription factors for optimal hematopoiesis. Likewise,
studies with knockout or overexpression of related bHLH
factors, such as E2A and Id2, support this view (Cochrane
et al., 2008; Engel and Murre, 2001; Ji et al., 2008). This redun-
dancy, coupled with dose sensitivity, has important implications
for the potential mechanisms that ensure fine-tuning of the
dynamic production of various blood cell components under
different types of demand.
Even though Lyl1 and Scl are functionally redundant in adult
HSCs, their relative roles during development and adult hemato-
poiesis appear to differ. Expression of Scl:Lyl1 chimeric proteins
(Porcher et al., 1999) suggests that protein-protein interactions
outside the bHLH mediate their distinct roles in development.
Furthermore, the observation that Scl null HSCs with one intact
allele of Lyl1 function relatively normally (Figure 1G), while Lyl1
null HSCs with one allele of Scl engraft very poorly (Figure 2B),
suggests that Lyl1 is more important for adult HSCs. Their
functional redundancy in adult HSCs may also account for their
similar contribution to human T cell leukemia when aberrantly ex-
pressed. Interestingly, LYL1-positive T-ALLs display more prim-
itive stem-cell-like characteristics than SCL-positive samples
(Ferrando et al., 2002), perhaps consistent with a more important
role for LYL1 in human HSCs, as our data suggest for murine
HSC. Further studies defining the common and distinct functions
of these key bHLH proteins will provide valuable insights in both




Mice with a floxed Scl allele (Sclfl/fl) and Lyl1/ mice were generated as
described before (Capron et al., 2006; Hall et al., 2003). Sclfl/fl were crossed
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Lyl1 Compensates for Scl in HSCto the Mx-Cre transgenic strain (Kuhn et al., 1995) and then to Lyl1/ mice;
their progeny was intercrossed to generate double knockouts, Lyl1/; Sclfl/fl ;
Mx-Cre. All mice are on a C57Bl/6 background and were housed in a specific-
pathogen-free animal facility, AALAC-accredited, at Baylor College of Medi-
cine (Houston, TX) or at Bio21 Institute (Melbourne, VIC).
Genotyping
Genomic DNA was isolated from mouse tails and digested in DNA lysis buffer
(Gerard Biotech). Primer sequences used for PCR amplification of the Lyl1
WT allele were 50-AAGCTGAGCAAGAACGAGGTGC-30 and 50-TCTGCTCCAA
CTTGATGGGTCTC-30, and for the lacZ knockin allele were 50-AGTGGGCGC
CCTCTGTCCTCTA-30 and 50-TAATTCGCGTCTGGCCTTCCTGTA-30. Primer
sequences used for PCR amplification of floxed and deleted Scl alleles
were 50-TCCCAAGCCCAAAGATTTCCCCAATG-30, 50-GCAAGCTGGATGGA
TCAACATGGACCT-30, and 50-ATGCTTGGATGCTTGGTTCAGAG-30. Primer
sequences used for PCR amplification of the Scl lacZ knockin allele were
50-GGATGGCGGGGCACACGAGGTAA-30 and 50-TGCCAGTTTGAGGGGAC
GACGACA-30.
Deletion of the Conditional Scl Allele
The Sclfl allele was deleted by inducing expression of the Mx-Cre by injecting
mice intraperitoneally between one and six times with 300 mg of polyinosinic-
polycytidylic acid [poly(I:C); Sigma (St. Louis, MO)] in PBS. The extent of dele-
tion was determined by performing either PCR or Southern blotting using
a probe that distinguishes floxed, deleted, and WT Scl alleles (Hall et al., 2003).
Peripheral Blood Analysis
For platelet counts, peripheral blood was collected from the retro-orbital
plexus into tubes containing potassium EDTA (Sarstedt, Nu¨mbrecht,
Germany) and analyzed with an Advia 120 automated hematological analyzer
(Bayer, Tarrytown, NY).
Semisolid Culture of Bone Marrow Progenitors
Bone marrow cells were cultured in 0.3% agar for 7 days, stained for acetyl-
cholinesterase, followed by Luxol Fast Blue and hematoxylin/eosin and
analyzed as described previously (Metcalf, 1984). Recombinant cytokines
were used at the following concentrations: 10 ng/ml mIL-3 (R&D Systems, Min-
neapolis, MN), 50 ng/ml SCF (Amgen Inc., Thousand Oaks, CA), and 10 ng/ml
human megakaryocyte growth and differentiation factor (MGDF; Amgen Inc.).
For BFU-E, bone marrow cells were plated in 0.9% methylcellulose for 7 days
with 10 ng/ml mIL-3, 50 ng/ml SCF, and 4 U/ml erythropoietin (EPO; Amgen
Inc.) and enumerated in situ after staining for hemoglobinized erythroid
colonies using 2,7-diaminofluorene.
Competitive Bone Marrow Transplantation Assays
Competitive bone marrow transplantation assays were performed by intrave-
nous injection of admixed CD45.2 donor whole bone marrow cells with CD45.1
competitor bone marrow. Lyl1 and Scl single- and double-knockout mice
carried the CD45.2 allele. Recipient C57Bl/6 mice had been lethally irradiated
with a split dose of 10.5 Gy, 3 hr apart. Sex- and age-matched C57Bl/6 mice
were used as competitors for every experiment. The competitor cell dose was
kept constant at 250,000 cells in all transplants except those shown in
Figure 1G, where the competitor dose was 500,000 cells.
Timed Matings and E14.5 Fetal Liver Transplants
Lyl1/ females in estrous were put together with Lyl1/+;ScllacZ/+ males and
were checked for vaginal plugs the next morning, designated as 0.5 days post-
coitum (dpc). At 14.5 dpc, fetal liver was dissected from the fetuses, and
single-cell suspensions were prepared in Hank’s balanced salt solution
(Gibco, Carlsbad, CA). Fetal liver cells were used in a 2:1 ratio with WT
competitor bone marrow in a transplantation assay as described above. The
genotypes were determined using a small amount of tissue from the fetuses
prior to the transplant, prepared, and genotyped as described above.
Flow Cytometry and Lineage Analysis
For peripheral blood analysis, mice were bled at 4, 8, 12, and 16 weeks post-
transplantation. Red blood cells were lysed and samples were stained with
CD45.1-APC, CD45.2-FITC, CD4-pacific blue, CD8-pacific blue, B220-pacific
blue, B220-PE-cy7, Mac1-PE-cy7, and Gr-1-PE-cy-7 antibodies (BD Pharmin-
gen, eBiosciences). FacsARIA, FacsCalibur, LSRII, and FACS-Scan flow
cytometers were used for analysis and sorting.
Methylcellulose Assay Colony PCR
Whole bone marrow from recipient animals was harvested, stained with
CD45.2-FITC antibody (eBiosciences), and sorted using a FACS-Aria.
CD45.2-positive cells were plated in Methocult GF M3434 (StemCell Technol-
ogies Inc.) or 0.3% agar as described and incubated at 37C, 5% CO2.
Colonies formed at approximately day 10 were picked, and DNA was isolated
(Gerard Biotech DNA isolation kit) and genotyped using the Scl-WT/floxed
primers used in mouse genotyping.
Annexin V and Cell Death Assays
Annexin V and PI or Fluoro-Gold staining was used to assess cell death and
apoptosis. Briefly, cells were washed twice with cold PBS and incubated at
room temperature in 13 binding buffer (10 mM HEPES, 140 mM NaCl,
2.5 mM CaCl2) containing either Annexin V-APC (BD-Pharmingen) and PI or
Annexin V-FITC, Sca1-PE, c kit-APC, lineage markers (B220, Ter119, Gr1,
Mac1, CD3)-PerCP/Cy5.5, and Fluoro-Gold. Cells were analyzed by flow
cytometry within 1 hr of staining.
Retroviral Transduction of Lyl1/;Sclfl/fl Cells
MSCV-Cre-IRES-GFP and MSCV-IRES-GFP retroviruses were generated as
previously described (Chambers et al., 2007). Transduced Sca1+ cells were
grown in culture for 48 hr, and Annexin V apoptosis analysis was performed
by flow cytometry.
SUPPLEMENTAL DATA
The Supplemental Data include two figures and can be found with this
article online at http://www.cell.com/cell-stem-cell/supplemental/S1934-
5909(09)00004-6.
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